Skip to main content
Fig. 13 | Bulletin of the National Research Centre

Fig. 13

From: Screening of Manilkara zapota (L) P. Royen stem bark ethanolic extract for in vitro α-glucosidase inhibition, preliminary antidiabetic effects, and improvement of diabetes and its complications in alloxan-induced diabetes in Wistar rats

Fig. 13

Assessment of cardio-vascular risk indices in alloxan-induced diabetic rats when treated with EMZSB. Values were presented as mean ± SEM (n = 6), statistics employed was two-way ANOVA followed by Tukey's multiple comparison test. $p < 0.05, #p < 0.01 when compared with normal control; *p < 0.05, **p < 0.01 when compared with diabetic control. Diabetic rats treated with EMZSB 250 mg kg−1 showed a significant decrease in cardiovascular risk indices. Gray bar normal control, red bar diabetic control, brown bar diabetic + glimepiride, blue bar diabetic + EMZSB 150, yellow bar diabetic + EMZSB 200, green bar diabetic + EMZSB 250

Back to article page